Brendan O'Grady; Chief Executive Officer; Assertio Holdings Inc. Ajay Patel; Chief Financial Officer, Senior Vice ...

Q4 2024 Earnings Call Transcript March 12, 2025 Assertio Holdings, Inc. misses on earnings expectations. Reported EPS is ...

Net Product Sales $29.6 Million, Cash Flow from Operations of $11.5 Million Full Year Net Product Sales $120.8 Million, Rolvedon Sales Exceed $60.0 Million Full Year Cash Flow from ...

Assertio Holdings Inc (ASRT) reports strong Rovedon sales and strategic leadership additions, while navigating legal and competitive pressures.

To explain a little more why I characterized 2024, as a stabilization year Assertio was coming off the acquisition and integration of Spectrum, and the subsequent loss of exclusivity of Indocin.

Net Product Sales $29.6 Million, Cash Flow from Operations of $11.5 MillionFull Year Net Product Sales $120.8Million, Rolvedon ...

Long-term use of NSAIDs has been linked to a reduced risk of developing dementia due to their anti-inflammatory properties. A large study highlights the importance of sustained use, rather than ...

Medically reviewed by Elizabeth Barnes, RDN Popular liver supplements such as milk thistle, artichoke, dandelion, turmeric, ...